The European Commission reportedly approved the drug Yellox (Bromfenac sodium sesquihydrate) by the European commission. The only twice-daily, ocular NSAID was developed by Croma Pharma, a Bausch + Lomb company. That summarizes the start of the MedicalNewsToday article. Read more.
No comments:
Post a Comment